Merck & Co., Inc. (MRK) NYSE

113.40

-0.05(-0.04%)

Updated at May 14 10:05AM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Robert Davis	Chairman, President & Chief Executive Officer	4.63M	1967
Chirfi Guindo	Executive Vice President of Strategic Access, Policy & Communications	1.54M	1966
Sanat Chattopadhyay	Executive Vice President & President of Merck Manufacturing Division	2.09M	1960
Richard R. DeLuca Jr.	Executive Vice President & President of Merck Animal Health	2.17M	1963
Jennifer L. Zachary	Executive Vice President & General Counsel	2.17M	1978
Betty D. Larson	Executive Vice President & Chief Human Resources Officer	2.29M	1976
Caroline Litchfield	Executive Vice President & Chief Financial Officer	2.4M	1969
Dean Y. Li	Executive Vice President & President of Merck Research Laboratories	3M	1963
Eric H. Rubin	Senior Vice President of Global Clinical Oncology & Early-stage Oncology	0	1960
Dalton E. Smart	Senior Vice President of Finance, Principal Accounting Officer & Global Controller	0	1967
David Michael Williams	Executive Vice President and Chief Information & Digital Officer	0	1969
Johannes J. Oosthuizen	Executive VP and President of Oncology & MSD International	0	1968
Eliav Barr	Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories	0	1965
Joerg Koglin	Senior VP & Head of General Medicine - Global Clinical Development	0	N/A
Peter Dannenbaum	Vice President of Investor Relations	0	N/A

Name

Title

Pay

Year Born

Robert Davis

Chairman, President & Chief Executive Officer

4.63M

1967

Chirfi Guindo

Executive Vice President of Strategic Access, Policy & Communications

1.54M

1966

Sanat Chattopadhyay

Executive Vice President & President of Merck Manufacturing Division

2.09M

1960

Richard R. DeLuca Jr.

Executive Vice President & President of Merck Animal Health

2.17M

1963

Jennifer L. Zachary

Executive Vice President & General Counsel

2.17M

1978

Betty D. Larson

Executive Vice President & Chief Human Resources Officer

2.29M

1976

Caroline Litchfield

Executive Vice President & Chief Financial Officer

2.4M

1969

Dean Y. Li

Executive Vice President & President of Merck Research Laboratories

1963

Eric H. Rubin

Senior Vice President of Global Clinical Oncology & Early-stage Oncology

1960

Dalton E. Smart

Senior Vice President of Finance, Principal Accounting Officer & Global Controller

1967

David Michael Williams

Executive Vice President and Chief Information & Digital Officer

1969

Johannes J. Oosthuizen

Executive VP and President of Oncology & MSD International

1968

Eliav Barr

Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories

1965

Joerg Koglin

Senior VP & Head of General Medicine - Global Clinical Development

N/A

Peter Dannenbaum

Vice President of Investor Relations

N/A

Description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.